The soluble suppression of tumorigenicity 2 as a biomarker of early cardiac remodeling in bradycardia patients receiving permanent pacemaker therapy

AIM: This study aims to evaluate: the difference of soluble suppression of tumorigenicity 2 (sST2) level, a biomarker for cardiac remodeling and echocardiography parameters value prior to and 1 month after implantation; and the association between pacemaker parameters and pacemaker mode along with d...

Descripción completa

Detalles Bibliográficos
Autores principales: Iqbal, Mohammad, Santosa Putra, Iwan Cahyo, Bunawan, Rizki, Goenawan, Hanna, Akbar, Mohammad Rizki, Kartasasmita, Arief Sjamsulaksan, Kim, Young Hoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Science Ltd 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051037/
https://www.ncbi.nlm.nih.gov/pubmed/37006226
http://dx.doi.org/10.2144/fsoa-2023-0001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051037/
https://www.ncbi.nlm.nih.gov/pubmed/37006226
http://dx.doi.org/10.2144/fsoa-2023-0001

Ejemplares similares